Ionis Pharmaceuticals (IONS) Divestments (2016 - 2017)

Ionis Pharmaceuticals (IONS) posted quarterly Divestments of $2.5 million for Q1 2017, down 43.88% quarter-over-quarter from $4.5 million in Q4 2016.

Ionis Pharmaceuticals (IONS) Divestments (2016 - 2017) Analysis & Trends

Ionis Pharmaceuticals' Divestments history runs 2 years deep, the most recent figure standing at $2.5 million for Q1 2017.

  • In Q1 2017, Divestments changed N/A year-over-year to $2.5 million; the TTM figure through Dec 2017 stood at $2.5 million (down 43.88% YoY), while the FY2017 annual figure was $2.5 million, down 43.88% from the prior year.
  • Divestments for Q1 2017 stood at $2.5 million, down from $4.5 million in the prior quarter.
  • The five-year high for Divestments was $4.5 million in Q4 2016, with the low at $2.5 million in Q1 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 9.82 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - -13.21 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Ionis Pharmaceuticals 9.48 Bn 7.43 Bn 265.21 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2017 2.51 Mn
Dec 31, 2016 4.47 Mn